Related Experiment Video
Updated: Jun 1, 2026

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
Amyloid of the Candida albicans Ure2p prion domain is infectious and has an in-register parallel β-sheet structure
Abbi Engel1, Frank Shewmaker, Herman K Edskes
1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0830, USA.
Abstract:
Ure2p of Candida albicans (Ure2(albicans) or CaUre2p) can be a prion in Saccharomyces cerevisiae, but Ure2p of Candida glabrata (Ure2(glabrata)) cannot, even though the Ure2(glabrata) N-terminal domain is more similar to that of the S. cerevisiae Ure2p (Ure2(cerevisiae)) than Ure2(albicans) is. We show that the N-terminal N/Q-rich prion domain of Ure2(albicans) forms amyloid that is infectious, transmitting [URE3alb] to S. cerevisiae cells expressing only C. albicans Ure2p. Using solid-state nuclear magnetic resonance of selectively labeled C. albicans Ure2p(1-90), we show that this infectious amyloid has an in-register parallel β-sheet structure, like that of the S. cerevisiae Ure2p prion domain and other S. cerevisiae prion amyloids. In contrast, the N/Q-rich N-terminal domain of Ure2(glabrata) does not readily form amyloid, and that formed upon prolonged incubation is not infectious.
Insights
The prion domain of Candida albicans Ure2p forms infectious amyloid in yeast, unlike Candida glabrata Ure2p. This amyloid structure transmits the prion state, [URE3alb], to yeast cells expressing only C. albicans Ure2p.
Area of Science:
- Biochemistry
- Molecular Biology
- Mycology
Background:
- Prions are infectious proteins that can propagate their misfolded state.
- Ure2p is a protein in yeast that can form prions.
- The prion-forming ability of Ure2p varies between yeast species.
Purpose of the Study:
- To investigate why Ure2p from Candida albicans forms prions in Saccharomyces cerevisiae, while Ure2p from Candida glabrata does not.
- To characterize the structural basis of prion formation and infectivity for Candida albicans Ure2p.
Main Methods:
- Comparative analysis of Ure2p N-terminal domains from different Candida species.
- Amyloid formation assays.
- Prion infectivity transmission experiments in Saccharomyces cerevisiae.
- Solid-state nuclear magnetic resonance (ssNMR) spectroscopy of selectively labeled Ure2p fragments.
Main Results:
- The N-terminal prion domain of Candida albicans Ure2p forms infectious amyloid structures.
- This amyloid structure is capable of transmitting the [URE3alb] prion state to Saccharomyces cerevisiae.
- The infectious amyloid exhibits an in-register parallel β-sheet structure, similar to other known yeast prions.
- The N-terminal domain of Candida glabrata Ure2p does not readily form amyloid, and any formed amyloid is not infectious.
Conclusions:
- The N-terminal prion domain of Candida albicans Ure2p possesses the intrinsic ability to form infectious amyloids.
- Structural differences in the N-terminal domains dictate the prion-forming capacity and infectivity of Ure2p across different yeast species.
- The in-register parallel β-sheet structure is crucial for the infectivity of Ure2p prions.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Candidiasis
Subviral Agents
Antifungal Agents

